Lupin’s alliance partner, ForDoz has received approval from the Food and Drug Administration for doxorubicin hydrochloride liposome injection, 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) ...

Please provide your email address to receive an email when new articles are posted on . Irinotecan liposome injection combined with 5-FU/leucovorin and oxaliplatin prolonged OS compared with ...

Aurobindo Pharma’s subsidiary, Eugia Pharma Specialities, has obtained the Food and Drug Administration’s clearance for amphotericin B liposome for injection, 50 mg /vial, which is a generic of ...

PARIS--(BUSINESS WIRE)-- Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the United States Food and Drug Administration (FDA) has granted the company Fast Track designation for ...

Please provide your email address to receive an email when new articles are posted on . An irinotecan liposome injection regimen improved OS compared with standard chemotherapy among untreated ...

Key market opportunities include the rising global cancer incidence, demand for safer cancer therapies, early adoption of ...

Souderton, Pennsylvania, February 23, 2012 /PRNewswire/ — Galen, a Northern Ireland Pharmaceutical company, has acquired the chemotherapy agent, DaunoXome® (daunorubicin citrate liposome injection) ...

ROSEMONT, Ill., Dec. 14, 2022 /PRNewswire/ -- Capstone Development Services Company LLC ("Capstone") announced today that it has received approval from the U.S. Food and Drug Administration (FDA), as ...

In utero fetal gene transfer could provide an alternative to transgenic approaches for functional analysis of stage- and tissue-specific, cis-acting DNA regulatory elements. Stage-specific in utero ...

BANNOCKBURN, Ill.--(BUSINESS WIRE)--Baxalta Incorporated (NYSE: BXLT), a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and ...

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it has completed its acquisition of global oncology assets from Merrimack Pharmaceuticals, in Cambridge, ...